Publications by authors named "Elisa Correcher-Martinez"
Unlabelled: We aim to estimate the incidence rates (IRs) of SARS-CoV-2 infections stratified by disease severity and comorbidities in pediatric population and to describe the COVID-19 vaccination coverage in children with and without comorbidities. A population-based cohort study was conducted in 6 electronic healthcare records databases from Italy, Spain, and Norway. The study lasted from 1 January 2020 to the latest databases' available data in each site, i.
View Article and Find Full Text PDFWe test the robustness of the self-controlled risk interval (SCRI) design in a setting where time between doses may introduce time-varying confounding, using both negative control outcomes (NCOs) and quantitative bias analysis (QBA). All vaccinated cases identified from 5 European databases between 1 September 2020 and end of data availability were included. Exposures were doses 1-3 of the Pfizer, Moderna, AstraZeneca, and Janssen COVID-19 vaccines; outcomes were myocarditis and otitis externa (NCO).
View Article and Find Full Text PDFArticle Synopsis
- The study assessed bias in self-controlled designs examining the link between COVID-19 vaccines and myocarditis.
- Data from five European databases was analyzed, focusing on individuals who developed myocarditis after vaccination.
- Results showed a consistent harmful association with myocarditis after the second dose of both Pfizer and Moderna vaccines, while the first dose showed no effect, indicating limited bias in the study methods.
Objectives: We aimed to compare the risk of herpes zoster (HZ) in adults with and without laboratory-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
Methods: This retrospective dynamic cohort study analyzed data from a public healthcare database in Spain between November 2020 and October 2021. The main outcome was incident cases of HZ in individuals ≥18-year-old.